Health · The Hindu · National
Supreme Court wants cap on trade margin for all essential medicines and medical products
Source brief · The publisher’s headline and teaser, with a link to its report.
From The Hindu · National
Government proposes 30% trade-margin cap on patented and non-patented cancer medicines, but top court asks why a margin cap cannot be extended to all medicines and medical products; the court says the government has to ensure that DPCO-approved medicines, whose price is legally regulated, reach…
Behind this report
- News desk
- Health
- Published
- 2026-10-17T15:01:40.000Z
- Linked source records
- 4
Related source headlines
Read how the linked publishers describe the story. A list of reports is not independent verification.
- The Hindu · Health Govt. caps trade margins on 137 anti-cancer drugs
- The Hindu BusinessLine · Latest Govt notifies 30% cap on trade margins on 137 cancer drugs, new prices from November 9
- The Hindu · Health Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP
The available source material is a short summary. Check the linked reports for the full detail.
Institutions: Supreme Court
Topics: Supreme Court
Sources and further reading
- The Hindu · National — Supreme Court wants cap on trade margin for all essential medicines and medical products
- The Hindu · Health — Govt. caps trade margins on 137 anti-cancer drugs
- The Hindu BusinessLine · Latest — Govt notifies 30% cap on trade margins on 137 cancer drugs, new prices from November 9
- The Hindu · Health — Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP